The Incidence and Timing of Blood Cultures in Multiple Myeloma - Results from a Retrospective, Single Center, Real-World Study
Clin Hematol Int
.
2020 Aug 10;2(4):168-172.
doi: 10.2991/chi.k.200719.001.
eCollection 2020 Dec.
Authors
Agoston Gyula Szabo
1
2
,
Katrine Fladeland Iversen
1
2
,
Flemming Schønning Rosenvinge
3
,
Sören Möller
2
4
,
Torben Plesner
1
2
Affiliations
1
Department of Hematology, Vejle Hospital, Beriderbakken 4, Vejle 7100, Denmark.
2
University of Southern Denmark, J.B. Winsløws Vej 9 A, Odense C 5000, Denmark.
3
Department of Clinical Microbiology, Odense University Hospital, J.B. Winsløws Vej 4, Odense C 5000, Denmark.
4
OPEN - Open Patient data Explorative Network, Odense University Hospital and Department of Clinical Research, Odense C 5000, Denmark.
PMID:
34595458
PMCID:
PMC8432406
DOI:
10.2991/chi.k.200719.001
No abstract available
Keywords:
Blood cultures; incidence; infection; multiple myeloma; risk factor.